Xenon Pharmaceuticals, Inc. (XENE)
44.12
-0.21
(-0.47%)
USD |
NASDAQ |
Dec 30, 16:00
44.14
+0.02
(+0.03%)
After-Hours: 20:00
Xenon Pharmaceuticals Market Cap: 3.409B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 95.46M |
| Aurinia Pharmaceuticals, Inc. | 2.086B |
| Edesa Biotech, Inc. | 10.62M |
| Lexaria Bioscience Corp. | 13.53M |
| ProMIS Neurosciences, Inc. | 15.05M |
Market Cap Related Metrics
| PS Ratio | 463.67 |
| PEG Ratio | -0.2966 |
| Price to Book Value | 6.094 |
| Price | 44.12 |
| Earnings Yield | -8.80% |
| PEGY Ratio | -0.2966 |